AEK-9480606-2/10002/1

Novartis Pharma AG — FEI 3002807772

Refusal Details

Date
February 18, 2026
Country
Switzerland
Product Category
Drugs and Biologics
Product Code
61PDY26 METFORMIN (ANTI-DIABETIC)
Charges
75